Ligamex
Natural health product licensed in Canada
- Licence holder
- Trytan Health Inc. - Trytan Santé Inc.
- NPN or DIN-HM
- 80079491
- Status
- Active licence
- Licence date
- 16 August 2017
- Revision date
- 23 April 2021
- Form
- Crème
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Abies balsamea Source : Aiguilles | 0.2 % |
| l-Menthol Source : Mentha arvensis- Feuille | 4.1 % |
| Eucalyptus globulus Source : Feuille | 0.6 % |
| d-camphre Source : Cinnamomum camphora - Bois | 3.1 % |
Non-medicinal ingredients
Eau purifiée, Huile essentielle d'orange, Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Poly(acrylamide), Huile essentielle d'anis, Poly(sorbate) 85, Huile minérale, Triéthanolamine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Crème | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity, rashes and/or burning discomfort have been known to occur; in which case, discontinue use. If you experience pain, swelling or blistering, stop use and get medical help right away. If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
- Contre-indications
Do not use if If you are pregnant or breastfeeding.
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, seek urgent medical attention and call a Poison Control Center immediately. If symptoms persist or worsen, or re-occur within a few days, discontinue use and consult a health care practitioner. Not for oral use. Avoid contact with eyes and mucous membranes; if this happens, rinse thoroughly with vegetable oil. If you have epilepsy or asthma, consult a health care practitioner prior to use. Avoid exposure of applied area(s) to the sun.
Source
Official Health Canada record, licence 80079491
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging